Top compounds associated with response to SLC39A1


Feature Type Standardized
Nominal ANOVA
mRNA alisertib CTRPv2 pan-cancer AAC -0.082 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA NG-25 GDSC1000 pan-cancer AAC -0.081 0.01
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.078 0.01
mRNA Vorinostat gCSI pan-cancer AAC -0.15 0.01
mRNA decitabine CTRPv2 pan-cancer AAC -0.07 0.01
mRNA AT13387 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.081 0.01
Download CSV